From the clinical to the genetic diagnosis of Prader-Willi and Angelman syndromes

Cristina Camprubí-Sánchez, E. Gabau-Vila, J. Artigas-Pallarés, M. D. Coll-Sandiumenge, M. Guitart-Feliubadaló

Producció científica: Contribució a una revistaArticle de revisióRecercaAvaluat per experts

4 Cites (Scopus)


Introduction and development. Angelman syndrome (AS) is characterised by severe mental retardation (MR), the absence of language, ataxia and/or tremors in the extremities and a characteristic behavioural phenotype with a happy behaviour and hyperactivity. Patients often show signs of microcephaly and convulsions. Prader-Willi syndrome (PWS) is characterised by acute hypotonia and feeding problems in the neonatal period, and triggers an uncontrollable appetite in the infant that leads to obesity. Most patients have some degree of MR, behavioural disorders and hypogonadism. Both pathologies are caused by a number of genetic mechanisms that affect the 15q11-q13 region regulated by genomic imprinting, which means that only one of the two copies of the genes in this region will be functional, depending on which parent they come from. The physical or functional absence of genes that are only expressed by the mother's chromosome 15 causes PWS and gentic anomalies which affects the UBE3A gen mother's copy causes AS. Conclusions. It is important to confirm the clinical diagnosis and to establish the genetic mechanism responsible for the two syndromes, both for their consequences as regards the prognosis and for genetic counselling; it is therefore important to draw up a diagnostic algorithm. © 2006, Revista de Neurología.
Idioma originalEnglish
RevistaRevista de Neurologia
Estat de la publicacióPublicada - 1 de gen. 2006


Navegar pels temes de recerca de 'From the clinical to the genetic diagnosis of Prader-Willi and Angelman syndromes'. Junts formen un fingerprint únic.

Com citar-ho